# MindWalk Holdings Corp.: financial statements, quarterly

HYFT · Nasdaq · CIK 1715925 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/hyft.md) · [Financials](/companies/hyft/financials.md) · [Filings](/companies/hyft/filings.md) · [Insiders](/companies/hyft/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hyft/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2019-04-30) | period not labelled (2020-04-30) | FY2021 (2021-04-30) | FY2022 (2022-04-30) | FY2023 (2023-04-30) | FY2024 (2024-04-30) | FY2025 (2025-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.5](/filings/0001564590-21-049295.md) | [2.7](/filings/0001193125-22-205824.md) | [41.8](/filings/0000950170-24-087127.md) | [30.0](/filings/0000950170-25-099392.md) | [8.4](/filings/0000950170-25-099392.md) | [3.5](/filings/0000950170-25-099392.md) | [10.8](/filings/0000950170-25-099392.md) |
| Current assets | $m | not reported | [7.7](/filings/0001564590-21-049295.md) | [48.9](/filings/0001193125-22-205824.md) | [37.5](/filings/0000950170-23-032388.md) | [16.8](/filings/0000950170-24-087127.md) | [11.5](/filings/0000950170-25-099392.md) | [18.8](/filings/0000950170-25-099392.md) |
| Total assets | $m | not reported | [27.3](/filings/0001564590-21-049295.md) | [67.0](/filings/0001193125-22-205824.md) | [93.6](/filings/0000950170-23-032388.md) | [77.8](/filings/0000950170-24-087127.md) | [60.0](/filings/0000950170-25-099392.md) | [44.4](/filings/0000950170-25-099392.md) |
| Current liabilities | $m | not reported | [7.9](/filings/0001564590-21-049295.md) | [6.1](/filings/0001193125-22-205824.md) | [9.3](/filings/0000950170-23-032388.md) | [5.9](/filings/0000950170-24-087127.md) | [8.1](/filings/0000950170-25-099392.md) | [9.0](/filings/0000950170-25-099392.md) |
| Total liabilities | $m | not reported | [12.2](/filings/0001564590-21-049295.md) | [10.0](/filings/0001193125-22-205824.md) | [18.4](/filings/0000950170-23-032388.md) | [20.0](/filings/0000950170-24-087127.md) | [24.3](/filings/0000950170-25-099392.md) | [20.8](/filings/0000950170-25-099392.md) |
| Shareholders' equity | $m | [18.1](/filings/0001564590-21-049295.md) | [15.1](/filings/0001193125-22-205824.md) | [56.9](/filings/0000950170-24-087127.md) | [75.3](/filings/0000950170-24-087127.md) | [58.5](/filings/0000950170-25-099392.md) | [35.7](/filings/0000950170-25-099392.md) | [23.6](/filings/0000950170-25-099392.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 46,711,866 at 2026-04-30, from the cover of the [20-F filed 2026-07-23](/filings/0001193125-26-312694.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.